SCHEMBL31577344

SCHEMBL31577344

CNc1nc(Nc2ccc(S(=O)(=NC(=O)OC(C)(C)C)C(C)C)cc2)c(C(=O)OC)nc1-c1nc2ccncc2n1C

nearest known ligand 0.30

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 1/20 0.30
▸ CDK1 P06493 2/20 0.30
▸ CDK2 P24941 2/20 0.30
▸ KDR P35968 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30206222 0.81 GPR119 (0.32) —
SCHEMBL31577393 0.75 TP53 (0.31) —
SCHEMBL31577373 0.74 JAK2 (0.43) —
SCHEMBL31577281 0.73 RPS6KA5 (0.41) —
SCHEMBL31577303 0.71 JAK2 (0.32) —
SCHEMBL31577339 0.70 BMI1 (0.37) KDR
SCHEMBL31219609 0.68 ABL1 (0.37) CDK1CDK2KDR
SCHEMBL31577350 0.67 AOC3 (0.37) —
SCHEMBL31577293 0.65 RPS6KA5 (0.41) —
SCHEMBL30205929 0.64 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4373817-B1 SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2025-05-21 — — EP disclosed
Send feedback